Psychiatric Safety and Weight Loss Efficacy of Naltrexone/bupropion as Add-on to Antidepressant Therapy in Patients with Obesity or Overweight
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Psychiatric Safety and Weight Loss Efficacy of Naltrexone/bupropion as Add-on to Antidepressant Therapy in Patients with Obesity or Overweight
Authors
Keywords
-
Journal
JOURNAL OF AFFECTIVE DISORDERS
Volume 289, Issue -, Pages 167-176
Publisher
Elsevier BV
Online
2021-04-23
DOI
10.1016/j.jad.2021.04.017
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Obesity in adults: a clinical practice guideline
- (2020) Sean Wharton et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Does obesity and diabetes mellitus metastasize to the brain? “Metaboptosis” and implications for drug discovery and development
- (2019) Roger S. McIntyre et al. CNS SPECTRUMS
- Effort-based decision-making is affected by overweight/obesity in major depressive disorder
- (2019) Rodrigo B. Mansur et al. JOURNAL OF AFFECTIVE DISORDERS
- Characterizing, Assessing, and Treating Cognitive Dysfunction in Major Depressive Disorder
- (2018) Roger S. McIntyre et al. HARVARD REVIEW OF PSYCHIATRY
- Depression and Obesity: Integrating the Role of Stress, Neuroendocrine Dysfunction and Inflammatory Pathways
- (2018) Silvia R. S. Ouakinin et al. Frontiers in Endocrinology
- The long-term effect of bariatric surgery on depression and anxiety
- (2018) Hartej Gill et al. JOURNAL OF AFFECTIVE DISORDERS
- The interface of depression and obesity
- (2017) Nattinee Jantaratnotai et al. Obesity Research & Clinical Practice
- Obesity and Its Potential Effects on Antidepressant Treatment Outcomes in Patients with Depressive Disorders: A Literature Review
- (2016) Young Woo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors
- (2016) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Method-of-use study of naltrexone sustained release (SR)/bupropion SR on body weight in individuals with obesity
- (2016) Amy Halseth et al. Obesity
- Is increased antidepressant exposure a contributory factor to the obesity pandemic?
- (2016) S H Lee et al. Translational Psychiatry
- Recommendations for prevention of weight gain and use of behavioural and pharmacologic interventions to manage overweight and obesity in adults in primary care
- (2015) Paula Brauer et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
- (2013) P. Hollander et al. DIABETES CARE
- A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)
- (2013) Caroline M. Apovian et al. Obesity
- Intentional weight loss and changes in symptoms of depression: a systematic review and meta-analysis
- (2011) A N Fabricatore et al. INTERNATIONAL JOURNAL OF OBESITY
- Overweight, Obesity, and Depression
- (2010) Floriana S. Luppino et al. ARCHIVES OF GENERAL PSYCHIATRY
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2010) Frank L Greenway et al. LANCET
- Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial
- (2010) Thomas A. Wadden et al. Obesity
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started